Overview
Mark Sonderup practices in Cape Town, South Africa. Mr. Sonderup is rated as an Experienced expert by MediFind in the treatment of Liver Failure. His top areas of expertise are Hepatitis, Hepatitis B, Hepatitis C, and Acute Intermittent Porphyria.
His clinical research consists of co-authoring 82 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Liver Failure.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- HepatitisMr. Sonderup isDistinguished. Learn about Hepatitis.
- Hepatitis BMr. Sonderup isDistinguished. Learn about Hepatitis B.
- Advanced
- Acute Intermittent PorphyriaMr. Sonderup isAdvanced. Learn about Acute Intermittent Porphyria.
- Hepatitis CMr. Sonderup isAdvanced. Learn about Hepatitis C.
- Experienced
- Abdominal Obesity Metabolic SyndromeMr. Sonderup isExperienced. Learn about Abdominal Obesity Metabolic Syndrome.
- Acute Hepatic Porphyria (AHP)Mr. Sonderup isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Banti's SyndromeMr. Sonderup isExperienced. Learn about Banti's Syndrome.
- CholangitisMr. Sonderup isExperienced. Learn about Cholangitis.
- CirrhosisMr. Sonderup isExperienced. Learn about Cirrhosis.
- COVID-19Mr. Sonderup isExperienced. Learn about COVID-19.